Sangamo Therapeutics Inc (SGMO) support and resistance · rev $57.8M
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
This page maps Sangamo Therapeutics Inc (SGMO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
SGMO currently screens at market cap $74.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SGMO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SGMO quote page for the session range and the stock page for the full model.
Not investment advice.